Clinical Gastroenterology Vol.21 No.07 ( Jun, 2006)

Thesis List

• 1 Epidemiology of Liver Cancer in Japan
  Hideo Tanaka

• 1-2 Global Epidemiology of Liver Cancer
  Takeji Umemura

• 1-3 Mass Screening for Hepatocellular Carcinoma : Its Significance and Cost-effectiveness
  Yoshihiro Akahane

• 2-1-1 Occurrence of Hepatocellular Carcinoma in Chronic Hepatitis B and HBV-related Liver Cirrhosis
  Shinya Nagaoka

• 2-1-2 HCC Development from the Patients with Chronic Hepatitis C
  Naoki Hiramatsu

• 2-1-3 Hepatocellular Carcinoma Arising from HBV- and HCV-Negative Diseased Livers
  Tomoki Nakajima

• 2-2 Mechanism of HBV Related Carcinogenesis
  Mari Inada

• 2-3 HCV and Carcinogenesis
  Kyoji Moriya

• 2-4 Genetic Alterations in Hepatocarcinogenesis
  Katsuya Nagaoka

• 2-5 Analysis of Transcriptomes and Proteomes of Hepatocellular Carcinoma
  Masao Honda

• 3-1 Histological Classification of Hepatocellular Carcinoma (HCC)
  Osamu Nakashima

• 3-2 Precursor and Borderline Lesions of Hepatocellular Carcinoma
  Rie Shibata

• 4-1 High Risk Group of Hepatocellular Carcinoma
  Kenji Ikeda

• 4-2-1 Screening for Hepatocellular Carcinoma by Ultrasonography
  Tohru Goto

• 4-2-2 Diagnosis of Hepatocellular Carcinoma with Contrast Enhanced Ultrasonography
  Toyokazu Fukunaga

• 4-2-3 Diagnosis of Hepatocellular Carcinoma by CT and MRI
  Takeyuki Watadani

• 4-2-4 Angiographic Diagnosis of Hepatocellular Carcinoma
  Masatoshi Okazaki

• 4-2-5 Diagnosis of Malignant Hepatic Tumor with CT Hepatic Arteriography and CT Arterial Portography
  Hiroshi Kondo

• 4-3-1 Serological Diagnosis of Patients with Hepatocellular Carcinoma by AFP and L3 fraction
  Yutaka Aoyagi

• 4-3-2 Diagnosis and Evaluation of Therapeutic Effect by Tumor Marker
  Takashi Kumada

• 4-3-3 Glypican 3 is a Promising Diagnostic Marker for Hepatocellular Carcinoma
  Kiyotaka Watanabe

• 4-4-1 Diagnostic Algorithm for Hypervascular Hepatocellular Carcinoma
  Hironao Okubo

• 4-4-2 Diagnostic Strategy for Hypovascular Nodule of the Liver
  Namiki Izumi

• 5-1 Staging System for Hepatocellular Carcinoma
  Masatoshi Kudo

• 5-2-1 Hepatic Resection for Hepatocellular Carcinoma
  Hiroyuki Sugo

• 5-2-2 Percutaneous Ethanol Injection
  Shinichiro Okabe

• 5-2-3a Radiofrequency Ablation for Hepatocellular Carcinoma ; Indication, Methods and Evaluation of Treatment Effect
  Masatoshi Tanaka

• 5-2-3b Complication and Prevention of Radiofrequency Ablation
  Hiroshi Kasugai

• 5-2-3c Percutaneous Radiofrequency Ablation with Intrapleural Fluid Infusion / Intraperitoneal Fluid Infusion
  Takuma Teratani

• 5-2-3d Laparoscopic Radiofrequency Ablation for Hepatocellular Carcinoma
  Norio Isoda

• 5-2-4 Transcatheter Hepatic Arterial Chemoembolization and Evaluation of its Therapeutic Effect
  Hiroshi Sakaguchi

• 5-2-5a Hepatic Arterial Infusion Chemotherapy for the Treatment of Advanced HCC
  Masaharu Yoshikawa

• 5-2-5b Subcutaneous Interferon-alpha and Intra-arterial Infusion of 5-Fluorouracil Combined Therapy for Advanced Hepatocellular Carcinoma
  Hiroshi Wada

• 5-2-6 Living Donor Liver Transplantation for Hepatocellular Carcinoma
  Takashi Ito

• 5-2-7 Immunotherapy for Hepatocellular Carcinoma
  Akira Kanamoto

• 5-2-8 Radiotherapy for HCC (Conventional, Proton and Heavy Ion : Carbon)
  Yasushi Matsuzaki

• 5-3 Treatment Algorithm for Hepatocellular Carcinoma
  Norihiro Kokudo

• 5-4 Informed Consent of Treatment for Hepatocellular Carcinoma
  Fumie Kurokawa

• 6-1-1 Prevention of Hepatocellular Carcinoma by Interferon Treatment in Chronic Hepatitis C Patients
  Akinori Kasahara

• 6-1-2 Interferon Prevents Recurrence of HCV-Related Hepatocellular Carcinoma after Complete Resection of the Primary Tumor
  Shuhei Nishiguchi

• 6-1-3 The Prevention of Hepatocellular Carcinoma Development by the Improvement of Serum Transaminase in Patients with Hepatitis C
  Shinichi Ohkawa

• 6-2 Prevention of Hepatitis B Virus-Related Hepatocellular Carcinoma
  Nobuyoshi Fukushima

• 6-3 Chemoprevention of Liver Carcinogenesis
  Hisataka Moriwaki